DNDi statement endorsed by the WHO

[June, 2008]
In June 2008, before the G8 Summit in Japan, DNDi released a statement endorsed by the World Health Organization (WHO) urging the G8 governments to support both, control programmes and R&D initiatives for NTDs.

Research Appeal

[October 23, 2006]
On 23 October, 2006, the Chair of the Board, the Executive Director and partners of Drugs for Neglected Diseases initiative (DNDi), sent an open letter, which relates to the landmark World Health Organization (WHO) R&D Resolution 59.24, to all candidates for the WHO Director-General position.

Waking Up Governments for Research on Neglected Diseases

[Geneva – May 16, 2006 ]
The R&D Appeal launched in June 2005 by the Drugs for Neglected Diseases initiative (DNDi), its founding partners, Oxfam, and the BIOS initiative, urges governments to take greater leadership in R&D on neglected diseases.

Boosting Innovation for Neglected Diseases

[ June 8, 2005 ]
Call to governments to provide significant and sustained support to bring essential new drugs, vaccines, and diagnostics to people suffering and dying from neglected diseases.

CIPIH Report could change the lives of neglected patients

[ Geneva – April 5, 2006 ]
DNDi welcomes the final report of the WHO’s Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH). The report clearly states that it is imperative for governments to set global health priorities and promote innovation to develop and deliver much-needed medicines, vaccines, and diagnostics adapted to the needs of the sick and neglected in developing countries.

The gap is growing: More resources needed now for neglected diseases

[ Geneva – November 11, 2004 ]
Two important conferences convene this month that will decide the future of patients suffering from neglected diseases in the poorer countries of the world: The Ministerial Summit on Health Research, November 16-20 in Mexico City, and the Dutch Government / WHO “Priority Medicines for the Citizens of Europe and the World” meeting, 18 November in The Hague.